Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $67,125.34 +3.47%
Ethereum $2,012.35 +6.04%
BNB $628.77 +4.11%
Optimism $0.12 +8.39%
Arbitrum $0.10 +8.26%
Solana $86.37 +6.76%
Polygon $0.22 +2.77%
Cosmos $1.82 +1.16%
Avalanche $9.18 +6.16%

Bitcoin $67,125.34 +3.47%
Ethereum $2,012.35 +6.04%
BNB $628.77 +4.11%
Optimism $0.12 +8.39%
Arbitrum $0.10 +8.26%
Solana $86.37 +6.76%
Polygon $0.22 +2.77%
Cosmos $1.82 +1.16%
Avalanche $9.18 +6.16%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B